Sort   by:  
 Page size 
UnknownGeographical Heterogeneity of Multiple Sclerosis Prevalence in France.
Not available
S-EPMC5147922 | biostudies-literature
UnknownComparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosis.
Not available
S-EPMC6715507 | biostudies-literature
UnknownGenotype-phenotype correlation and course of transthyretin familial amyloid polyneuropathies in France.
Not available
S-EPMC4738459 | biostudies-literature
UnknownMD1003 (High-Dose Pharmaceutical-Grade Biotin) for the Treatment of Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Study.
Not available
S-EPMC6061426 | biostudies-literature
UnknownInvestigating the Long-term Effect of Pregnancy on the Course of Multiple Sclerosis Using Causal Inference.
Not available
S-EPMC10033171 | biostudies-literature
UnknownComparison of SimoaTM and EllaTM to assess serum neurofilament-light chain in multiple sclerosis.
Not available
S-EPMC8108418 | biostudies-literature
UnknownAssociation Between Anti-CD20 Therapies and COVID-19 Severity Among Patients With Relapsing-Remitting and Progressive Multiple Sclerosis.
Not available
S-EPMC10290250 | biostudies-literature
UnknownRelapses in Patients Treated with High-Dose Biotin for Progressive Multiple Sclerosis.
Not available
S-EPMC8116391 | biostudies-literature
UnknownHighly Effective Therapies as First-Line Treatment for Pediatric-Onset Multiple Sclerosis.
Not available
S-EPMC10862269 | biostudies-literature
UnknownComparative Effectiveness of Natalizumab Versus Anti-CD20 in Highly Active Relapsing-Remitting Multiple Sclerosis After Fingolimod Withdrawal.
Not available
S-EPMC9226262 | biostudies-literature
Sort   by:  
 Page size